Psychiatric Research Institute
July 7, 2021
Researcher Finds Challenges in Study Involving Methamphetamine
If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.
“Use meth?”
June 29, 2021
UAMS Physicians See Dramatic Increase In Postpartum Psychosis Cases during COVID-19 Pandemic
LITTLE ROCK — Postpartum psychosis is a serious, albeit rare illness, compared to the number of postpartum depression cases seen in the United States.
February 24, 2021
UAMS Received $3 Million to Reimburse Facilities that Provide Medication-Assisted Treatment for Opioid Use
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) recently received $3 million from the Arkansas Department of Human Services (DHS) to compensate facilities across the state providing medication-assisted treatment to opioid use disorder patients. The money will allow medical providers to offer treatment for opioid use disorder to patients without insurance or…
October 27, 2020
$250,000 Gift Supports Education, Research, Patient Care at UAMS Psychiatric Research Institute
The University of Arkansas for Medical Sciences (UAMS) has received a gift of $250,000 to support the priorities of the Psychiatric Research Institute on its Little Rock campus. The gift will have a far-reaching impact for patients across the state. The donor asked to remain anonymous. “I want to personally thank this donor for their…
October 21, 2020
Four Physicians Join UAMS Psychiatric Research Institute
LITTLE ROCK — The Psychiatric Research Institute (PRI) at the University of Arkansas for Medical Sciences (UAMS) recently added four new physicians to its faculty. Ming Hwei Yek, Psy.D., a clinical psychologist, is an assistant professor in the UAMS Department of Psychiatry. Yek received a master’s in Clinical Psychology from McGill University of Montreal and…
August 4, 2020
AR-Connect Links Arkansans With Virtual Care For Mental Illness, Stress Related to COVID-19
LITTLE ROCK – Arkansans experiencing mental health issues or stress related to the COVID-19 pandemic may receive immediate help 24 hours a day through the AR-Connect program at the University of Arkansas for Medical Sciences (UAMS) with no out-of-pocket cost to the patient. The program began in May and offers the opportunity to talk to…
June 26, 2020
George and Linda Gleason Foundation Gives $100,000 for UAMS Psychiatric Research Institute, Department of Neurology
The George and Linda Gleason Foundation has given $100,000 to the University of Arkansas for Medical Sciences (UAMS), split evenly among the Department of Neurology in the College of Medicine and the Psychiatric Research Institute. The Gleasons were on hand Friday, June 19 to present a check to R. Lee Archer, M.D., chair of the…
May 28, 2020
Depression, Anxiety For Many Relieved with Free Cell Phone App, Researchers Find
A cell phone app designed to treat depression showed a dramatic reduction in symptoms compared to those who relied on other methods or received no treatment at all, according to a recent University of Arkansas for Medical Sciences (UAMS) study. The results of the study were published earlier this month in the American Medical Association’s…
May 14, 2020
AR-Connect Provides for Urgent Behavioral Health Needs
For people living with behavioral health issues, the COVID-19 pandemic has brought new challenges to maintaining well-adjusted lives. Imagine this scenario. A man living out of state returns to his Arkansas home to run errands for his aging parents, thus helping protect them from exposure to the virus. Before moving home, his bipolar disorder was…
April 20, 2020
Sensory Room Lets Kids Work Through Problems
A room once intended for isolating patients in distress has become a favorite of the UAMS Psychiatric Research Institute’s youngest charges, thanks to the addition of a number of components designed to both calm and stimulate them. The Child Diagnostic Unit, an inpatient unit for patients 2 to 12 years old, was intended to be…
Previous page Next page